U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C15H13NO
Molecular Weight 223.2698
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 2-ACETYLAMINOFLUORENE

SMILES

CC(=O)NC1=CC=C2C(CC3=C2C=CC=C3)=C1

InChI

InChIKey=CZIHNRWJTSTCEX-UHFFFAOYSA-N
InChI=1S/C15H13NO/c1-10(17)16-13-6-7-15-12(9-13)8-11-4-2-3-5-14(11)15/h2-7,9H,8H2,1H3,(H,16,17)

HIDE SMILES / InChI

Molecular Formula C15H13NO
Molecular Weight 223.2698
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

PubMed

PubMed

TitleDatePubMed
Evidence of a "clear and consistent threshold" for bladder and liver cancer in the large ED01 carcinogenicity study.
2003-08
Uncoupling of leading- and lagging-strand DNA replication during lesion bypass in vivo.
2003-05-23
Use of HepG2 cell line for direct or indirect mutagens screening: comparative investigation between comet and micronucleus assays.
2003-04-20
Mechanistic insights into replication across from bulky DNA adducts: a mutant polymerase I allows an N-acetyl-2-aminofluorene adduct to be accommodated during DNA synthesis.
2003-04-08
Differentially expressed transcripts in neoplastic hepatic nodules and neonatal rat liver studied by cDNA microarray analysis.
2003-03-20
Suppressive effect of herbal compound 861 on chemical hepatocarcinogenesis in rats.
2003-03
Thresholds of carcinogenicity in the ED01 study.
2003-03
Different effects of the liver mitogens triiodo-thyronine and ciprofibrate on the development of rat hepatocellular carcinoma.
2003-02-25
Prevalidation of a rat liver foci bioassay (RLFB) based on results from 1600 rats: a study report.
2003-02-25
Pregnane X receptor-dependent and -independent effects of 2-acetylaminofluorene on cytochrome P450 3A23 expression and liver cell proliferation.
2003-01-10
Polychlorinated biphenyls as initiators in liver carcinogenesis: resistant hepatocyte model.
2003-01-01
Suppressive effect of Astragalus membranaceus Bunge on chemical hepatocarcinogenesis in rats.
2003-01
Mutagenic activation of arylamines by subcellular fractions of Chamaelea gallina clams exposed to environmental pollutants.
2003
Use of nucleotide excision repair-deficient mice as a model for chemically induced lung cancer.
2003
Distinction of carcinogens from mutagens by induction of liver cell foci in a model for detection of initiation activity.
2002-12-15
Mutagenic events in Escherichia coli and mammalian cells generated in response to acetylaminofluorene-derived DNA adducts positioned in the Nar I restriction enzyme site.
2002-12-03
Oxidative DNA damage by a common metabolite of carcinogenic nitrofluorene and N-acetylaminofluorene.
2002-12-01
Deacylation of N-arylformamides and N-arylacetamides by formamidase in rat liver.
2002-12
Protection by beverages, fruits, vegetables, herbs, and flavonoids against genotoxicity of 2-acetylaminofluorene and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in metabolically competent V79 cells.
2002-11-26
Influence of different chemicals on MDR-1 P-glycoprotein expression and activity in the HK-2 proximal tubular cell line.
2002-09-01
The Liverbeads as a tool for the comet assay.
2002-08-26
Chemical models for cytochrome P450 as a biomimetic metabolic activation system in mutation assays.
2002-08-26
Hydrocortisone affects the N-acetylation of 2-aminofluorene and DNA-2-aminofluorene adduct formation in Sprague-Dawley rats.
2002-08-10
Trapping of DNA nucleotide excision repair factors by nonrepairable carcinogen adducts.
2002-08-01
Anticarcinogenicity of monocyclic phenolic compounds.
2002-08
Embryoid-body cells derived from a mouse embryonic stem cell line show differentiation into functional hepatocytes.
2002-07
The isomerization of the UvrB-DNA preincision complex couples the UvrB and UvrC activities.
2002-06-28
[Establishment and optimization of rat models for hepatic oval cells proliferation].
2002-06
In vivo cell lineage analysis during chemical hepatocarcinogenesis in rats using retroviral-mediated gene transfer: evidence for dedifferentiation of mature hepatocytes.
2002-06
Pleiotrophin/heparin-binding growth-associated molecule as a mitogen of rat hepatocytes and its role in regeneration and development of liver.
2002-06
Alterations of the Fhit gene in hepatocellular carcinomas induced by N-nitrosodiethylamine in rats.
2002-05
The effect of paclitaxel on 2-aminofluorene-DNA adducts formation and arylamine N-acetyltransferase activity and gene expression in human lung tumor cells (A549).
2002-05
Genomic structure, gene expression, and promoter analysis of human multidrug resistance-associated protein 7.
2002-04-25
Polyetheretherketone--cytotoxicity and mutagenicity in vitro.
2002-04
The in vivo apoptotic effect of interferon alfa-2b on rat preneoplastic liver involves Bax protein.
2002-04
Acute cytotoxicity of the chemical carcinogen 2-acetylaminofluorene in cultured rat liver epithelial cells.
2002-03-28
Induction of human MDR1 gene expression by 2-acetylaminofluorene is mediated by effectors of the phosphoinositide 3-kinase pathway that activate NF-kappaB signaling.
2002-03-27
Alteration of liver cell function and proliferation: differentiation between adaptation and toxicity.
2002-03-14
32P-Postlabeling/polyacrylamide gel electrophoresis analysis: application to the detection of DNA adducts.
2002-03
Genetics of mutagenesis in E. coli: various combinations of translesion polymerases (Pol II, IV and V) deal with lesion/sequence context diversity.
2002-02-28
Germ cells microsatellite instability. The effect of different mutagens in a mismatch repair mutant of Drosophila (spel1).
2002-02-15
Lack of DNA binding in the rat nasal mucosa and other tissues of the nasal toxicants roflumilast, a phosphodiesterase 4 inhibitor, and a metabolite, 4-amino-3,5-dichloropyridine, in contrast to the nasal carcinogen 2,6-dimethylaniline.
2002-02
In vivo cell lineage analysis in cyproterone acetate-treated rat liver using genetic labeling of hepatocytes.
2002-02
Proliferation and differentiation of ductular progenitor cells and littoral cells during the regeneration of the rat liver to CCl4/2-AAF injury.
2002-01
SDF-1alpha/CXCR4: a mechanism for hepatic oval cell activation and bone marrow stem cell recruitment to the injured liver of rats.
2002
Effects of garlic components diallyl sulfide and diallyl disulfide on arylamine N-acetyltransferase activity and 2-aminofluorene-DNA adducts in human promyelocytic leukemia cells.
2002
The drug efflux pump MRP2: regulation of expression in physiopathological situations and by endogenous and exogenous compounds.
2002
Anti-mutagenic activity of Phyllanthus amarus Schum & Thonn in vitro as well as in vivo.
2002
Ellagic [correction of ellagica] acid inhibits arylamine N-acetyltransferase activity and DNA adduct formation in human bladder tumor cell lines (T24 and TSGH 8301).
2001-12
Leukemia inhibitory factor decreases the arylamine N-acetyltransferase activity in human cumulus granulosa cells.
2001-12
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:44:06 GMT 2025
Edited
by admin
on Mon Mar 31 18:44:06 GMT 2025
Record UNII
9M98QLJ2DL
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
2-ACETYLAMINOFLUORENE
HSDB  
Systematic Name English
N-2-FLUORENYLACETAMIDE
MI  
Preferred Name English
2-FAA
Common Name English
ACETYLAMINOFLUORENE, 2-
Systematic Name English
ACETAMIDE, N-9H-FLUOREN-2-YL-
Systematic Name English
2-ACETYLAMINOFLUORENE [HSDB]
Common Name English
N-2-FLUORENYLACETAMIDE [MI]
Common Name English
N-ACETYL-2-AMINOFLUORENE
Systematic Name English
C15-H13-N-O
Common Name English
AAF
Common Name English
NSC-12279
Code English
N-9H-FLUOREN-2-YLACETAMIDE
Systematic Name English
Classification Tree Code System Code
NCI_THESAURUS C45176
Created by admin on Mon Mar 31 18:44:07 GMT 2025 , Edited by admin on Mon Mar 31 18:44:07 GMT 2025
Code System Code Type Description
MERCK INDEX
m5459
Created by admin on Mon Mar 31 18:44:07 GMT 2025 , Edited by admin on Mon Mar 31 18:44:07 GMT 2025
PRIMARY Merck Index
NSC
12279
Created by admin on Mon Mar 31 18:44:07 GMT 2025 , Edited by admin on Mon Mar 31 18:44:07 GMT 2025
PRIMARY
HSDB
4077
Created by admin on Mon Mar 31 18:44:07 GMT 2025 , Edited by admin on Mon Mar 31 18:44:07 GMT 2025
PRIMARY
PUBCHEM
5897
Created by admin on Mon Mar 31 18:44:07 GMT 2025 , Edited by admin on Mon Mar 31 18:44:07 GMT 2025
PRIMARY
ECHA (EC/EINECS)
200-188-6
Created by admin on Mon Mar 31 18:44:07 GMT 2025 , Edited by admin on Mon Mar 31 18:44:07 GMT 2025
PRIMARY
WIKIPEDIA
2-ACETYLAMINOFLUORENE
Created by admin on Mon Mar 31 18:44:07 GMT 2025 , Edited by admin on Mon Mar 31 18:44:07 GMT 2025
PRIMARY
MESH
D015073
Created by admin on Mon Mar 31 18:44:06 GMT 2025 , Edited by admin on Mon Mar 31 18:44:06 GMT 2025
PRIMARY
EPA CompTox
DTXSID0039227
Created by admin on Mon Mar 31 18:44:07 GMT 2025 , Edited by admin on Mon Mar 31 18:44:07 GMT 2025
PRIMARY
CHEBI
17356
Created by admin on Mon Mar 31 18:44:07 GMT 2025 , Edited by admin on Mon Mar 31 18:44:07 GMT 2025
PRIMARY
NCI_THESAURUS
C29791
Created by admin on Mon Mar 31 18:44:06 GMT 2025 , Edited by admin on Mon Mar 31 18:44:06 GMT 2025
PRIMARY
MESH
C118533
Created by admin on Mon Mar 31 18:44:06 GMT 2025 , Edited by admin on Mon Mar 31 18:44:06 GMT 2025
PRIMARY
FDA UNII
9M98QLJ2DL
Created by admin on Mon Mar 31 18:44:07 GMT 2025 , Edited by admin on Mon Mar 31 18:44:07 GMT 2025
PRIMARY
CAS
53-96-3
Created by admin on Mon Mar 31 18:44:06 GMT 2025 , Edited by admin on Mon Mar 31 18:44:06 GMT 2025
PRIMARY